Angel · USA
Zygote invests first or very early in technology, biotech, and agriculture companies that can 'change the game' and improve the world in a meaningful way. As a principal-only investor with no limited partners, Zygote is less risk-averse than traditional VCs and can choose to partner where it can provide real value.
Business models
deeptech_ip, platform, hardware
Customer segments
Enterprise, Healthcare providers, Agriculture
Geography
US
+ 2 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Zygote Ventures writes individual checks. Angels carry outsized signal early — the right names on a SAFE turn warm intros to institutional rounds faster than any other lever — and they decide in hours, not weeks. VC Boom tracks Zygote Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Act Venture Capital
DeepTech, AI, SaaS
Seed VC
ACT Venture Partners
DeepTech, Aerospace, AI
Seed VC
Action Potential Venture Capital
DeepTech, Healthtech, Biotech
Seed VC
Activant Capital
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
Activate Venture Partners
DeepTech, AI, Healthtech
Seed VC
Active Impact Investments
Climate Tech, Energy, Food and agritech
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Zygote Ventures is one of them — and we'll tell you exactly where they sit in your top 100.